NO20011381D0 - Streptococcal C <beta> protein preparations - Google Patents

Streptococcal C <beta> protein preparations

Info

Publication number
NO20011381D0
NO20011381D0 NO20011381A NO20011381A NO20011381D0 NO 20011381 D0 NO20011381 D0 NO 20011381D0 NO 20011381 A NO20011381 A NO 20011381A NO 20011381 A NO20011381 A NO 20011381A NO 20011381 D0 NO20011381 D0 NO 20011381D0
Authority
NO
Norway
Prior art keywords
streptococcal
beta
protein preparations
preparations
protein
Prior art date
Application number
NO20011381A
Other languages
Norwegian (no)
Other versions
NO20011381L (en
Inventor
Karen O Long-Rowe
Milan S Blake
Original Assignee
Baxter Biotech Tech Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Tech Sarl filed Critical Baxter Biotech Tech Sarl
Publication of NO20011381L publication Critical patent/NO20011381L/en
Publication of NO20011381D0 publication Critical patent/NO20011381D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
NO20011381A 1998-09-17 2001-03-19 Streptococcal C <beta> protein preparations NO20011381D0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10085998P 1998-09-17 1998-09-17
US14432499P 1999-07-19 1999-07-19
US15401799P 1999-09-15 1999-09-15
PCT/US1999/021643 WO2000015760A1 (en) 1998-09-17 1999-09-17 Streptococcal c beta protein compositions

Publications (2)

Publication Number Publication Date
NO20011381L NO20011381L (en) 2001-03-19
NO20011381D0 true NO20011381D0 (en) 2001-03-19

Family

ID=27379089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011381A NO20011381D0 (en) 1998-09-17 2001-03-19 Streptococcal C <beta> protein preparations

Country Status (10)

Country Link
EP (1) EP1114143A4 (en)
JP (1) JP2002525041A (en)
AU (1) AU6049599A (en)
CA (1) CA2343051A1 (en)
CZ (1) CZ2001951A3 (en)
HU (1) HUP0103502A2 (en)
NO (1) NO20011381D0 (en)
PL (1) PL347058A1 (en)
SK (1) SK3482001A3 (en)
WO (1) WO2000015760A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
JP2013537531A (en) 2010-08-04 2013-10-03 トーマス・ジュリアス・ボロディ Composition for faecal flora transplantation and methods for making and using it and device for delivering the same
AU2012225305B2 (en) 2011-03-09 2017-06-08 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
IN2014DN07752A (en) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
JP6868562B2 (en) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス, インコーポレイテッド Methods and compositions for microbial treatment and diagnosis of disorders
KR102561989B1 (en) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN108243608A (en) 2015-05-22 2018-07-03 亚利桑那大学董事会 For treating autism spectrum disorder and related indication method
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (en) 2017-08-07 2020-06-23 芬奇治疗公司 Compositions and methods for maintaining and restoring a healthy intestinal barrier
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757134A (en) * 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
WO1998009648A1 (en) * 1996-09-06 1998-03-12 North American Vaccine, Inc. NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS

Also Published As

Publication number Publication date
PL347058A1 (en) 2002-03-11
NO20011381L (en) 2001-03-19
CA2343051A1 (en) 2000-03-23
AU6049599A (en) 2000-04-03
WO2000015760A1 (en) 2000-03-23
SK3482001A3 (en) 2002-02-05
JP2002525041A (en) 2002-08-13
HUP0103502A2 (en) 2002-01-28
EP1114143A1 (en) 2001-07-11
CZ2001951A3 (en) 2001-11-14
EP1114143A4 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
NO20011381D0 (en) Streptococcal C &lt;beta&gt; protein preparations
CY2006006I1 (en) PROTEIN FORMULATIONS
DK1135139T3 (en) Preparations containing micronized eplerenone
IS6040A (en) Valdekoxib preparations
ATE285788T1 (en) ACTIVATED PROTEIN C FORMULATIONS
NO20006268D0 (en) &lt;Beta&gt; karbolinforbindelser
NO20005337L (en) Polyol-IFN- &lt;BETA&gt; conjugates
DE69907145D1 (en) HAIRSTYLING SHAMPOO COMPOSITION
NO20015859L (en) A- &lt;beta&gt; peptide preparations and methods for their preparation
DK0988861T3 (en) Stabilized protein preparations
DE69518331T2 (en) ORAL PREPARATIONS
DE59910159D1 (en) Radiation-curable preparations
ID29065A (en) TRANSFERAGE PROTEIN FARNESIL OBSTACLES
DE69827484D1 (en) STABILIZED TIBOLONE PREPARATIONS
DK1109450T3 (en) The microcapsule preparations
DE59707298D1 (en) DESODORING PREPARATIONS
DE69926012D1 (en) PHARMACEUTICAL PREPARATIONS
DE69432149T2 (en) Oral preparations
ATE246494T1 (en) EFFORTABLE PREPARATIONS
AU4202699A (en) Human socs proteins
DE59908817D1 (en) AQUEOUS PREPARATIONS
NO20004167D0 (en) Caspase-8 interacting proteins
DK1051487T3 (en) Placental protein 13
ATE295417T1 (en) ANGIOSTATIN-BINDING PROTEIN
DE69906934D1 (en) PHARMACEUTICAL PREPARATIONS